TB/HIV/Oncology Generics Portfolio

About Pharmasyntez

Pharmasyntez is a major, vertically integrated Russian generics and API producer with a significant domestic manufacturing footprint. The company has established itself as a key player in addressing critical public health needs, particularly in anti-tuberculosis, HIV, and oncology therapeutics, through both in-house production and extensive R&D collaborations with Russian academic institutions. While primarily serving the Russian market, it expresses openness to international partnerships for technology transfer and co-development. Its strategy is aligned with national priorities for pharmaceutical import substitution and localization of production.

Therapeutic Areas